Dateline City:
KENILWORTH, N.J.
Unveils Positively Committed Campaign at International AIDS Society Conference
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada,
announced today that the company's commitment to HIV and AIDS, which
started with a research and development program initiated in the
mid-1980s during the early years of the epidemic, is now entering its
fourth decade.
Language:
English
Contact:
MerckMedia:Pam Eisele, 267-305-3558orCarmen de Gourville, 267-305-4195orInvestor:Joe Romanelli, 908-740-1986orJustin Holko, 908-740-1879
Ticker Slug:
Ticker: MRK Exchange: NYSE
read more